1 completed, 1 recruiting, 1 terminated, 1 unknown. 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Recruiting 1, Terminated 1 |
Follow Zolendronic Acid: new trials by email Literature Review of Zolendronic Acid trials Research Report on Zolendronic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RANK-ligand Inhibition to Combat Sarcopenia With Underlying Osteoporosis Denosumab, Zolendronic Acid - Sarcopenia in Elderly | Phase 4 | Recruiting | Prince of Wales Hospital, Shatin, Hong Kong | 120 | 2024-04-09 | 2026-09-18 |
| Zometa Study in Pediatric Acute Lymphoblastic Leukemia zolendronic acid, calcium & vitamin D - Osteoporosis | Phase 3 | Completed | Children's Cancer Hospital Egypt 57357 | 95 | 2011-10-01 | 2018-04-17 |
| Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer Letrozole, Zolendronic Acid - Breast Neoplasms | Phase 4 | Terminated | Novartis Pharmaceuticals | 168 | 2006-06-01 | 2017-06-26 |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Unknown | Wales Cancer Trials Unit | 1404 | 2006-01-01 | 2013-03-13 |
Breast Neoplasms (2) · Breast Neoplasms, Male (1) · Humoral Hypercalcemia Of Malignancy (1) · Neoplasm Metastasis (1) · Osteoporosis (1)
Children's Cancer Hospital Egypt 57357 (1) · Novartis Pharmaceuticals (1) · Prince of Wales Hospital, Shatin, Hong Kong (1) · Wales Cancer Trials Unit (1)
China (1) · Egypt (1) · Germany (1) · United Kingdom (1)
Peter J. Barrett Lee, MD (1) · Shimaa Samir, MBBCH (1)
PMID 24332514, PMID 28274254, PMID 38979716, PMID 40760465
2004 (1)